30% via epoetin administration in patients with congestive heart failure or ischemic heart disease undergoing dialysis showed a trend towards increased mortality and myocardial infarctions, [21] so there potentially could be some risk in using higher targets in this population.
← all excerpts
Cardiovascular effects of hemoglobin response in patients receiving epoetin alfa and oral iron in heart failure with a preserved ejection fraction.
1
—
—